Nuwellis, Inc. (NUWE)
USD 1.06
(2.88%)
USD 1.06
(2.88%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 221 Thousand USD | -70.92% |
| 2022 | 760 Thousand USD | -22.76% |
| 2021 | 984 Thousand USD | 802.75% |
| 2020 | 109 Thousand USD | -58.24% |
| 2019 | 261 Thousand USD | 0.0% |
| 2018 | - USD | 0.0% |
| 2017 | - USD | 0.0% |
| 2016 | - USD | -100.0% |
| 2015 | 3.94 Million USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | 0.0% |
| 2011 | - USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | 0.0% |
| 2005 | - USD | 0.0% |
| 2004 | - USD | 0.0% |
| 2003 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 428 Thousand USD | 0.0% |
| 2024 Q1 | 2000.00 USD | 0.0% |
| 2023 Q2 | 654 Thousand USD | -7.63% |
| 2023 Q4 | 221 Thousand USD | -63.23% |
| 2023 Q3 | 601 Thousand USD | -8.1% |
| 2023 FY | 221 Thousand USD | -70.92% |
| 2023 Q1 | 708 Thousand USD | -6.84% |
| 2022 FY | 760 Thousand USD | -22.76% |
| 2022 Q4 | 760 Thousand USD | -6.17% |
| 2022 Q2 | 875 Thousand USD | -6.02% |
| 2022 Q1 | 931 Thousand USD | -5.39% |
| 2022 Q3 | 810 Thousand USD | -7.43% |
| 2021 Q2 | 41 Thousand USD | -14.58% |
| 2021 Q1 | 48 Thousand USD | -55.96% |
| 2021 FY | 984 Thousand USD | 802.75% |
| 2021 Q4 | 984 Thousand USD | 2881.82% |
| 2021 Q3 | 33 Thousand USD | -19.51% |
| 2020 Q4 | 109 Thousand USD | -35.12% |
| 2020 Q1 | 212 Thousand USD | -18.77% |
| 2020 FY | 109 Thousand USD | -58.24% |
| 2020 Q2 | 206 Thousand USD | -2.83% |
| 2020 Q3 | 168 Thousand USD | -18.45% |
| 2019 Q2 | 357 Thousand USD | -11.41% |
| 2019 Q3 | 309 Thousand USD | -13.45% |
| 2019 Q4 | 261 Thousand USD | -15.53% |
| 2019 FY | 261 Thousand USD | 0.0% |
| 2019 Q1 | 403 Thousand USD | 0.0% |
| 2018 FY | - USD | 0.0% |
| 2018 Q4 | - USD | 0.0% |
| 2018 Q3 | - USD | 0.0% |
| 2018 Q2 | - USD | 0.0% |
| 2018 Q1 | - USD | 0.0% |
| 2017 Q4 | - USD | 0.0% |
| 2017 Q3 | - USD | 0.0% |
| 2017 FY | - USD | 0.0% |
| 2017 Q2 | - USD | 0.0% |
| 2017 Q1 | - USD | 0.0% |
| 2016 Q4 | - USD | 0.0% |
| 2016 FY | - USD | -100.0% |
| 2016 Q2 | 1.96 Million USD | -33.03% |
| 2016 Q1 | 2.93 Million USD | -25.55% |
| 2016 Q3 | - USD | -100.0% |
| 2015 Q4 | 3.94 Million USD | -19.24% |
| 2015 FY | 3.94 Million USD | 0.0% |
| 2015 Q2 | 5.8 Million USD | 15.03% |
| 2015 Q3 | 4.88 Million USD | -15.88% |
| 2015 Q1 | 5.04 Million USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2012 Q1 | - USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2006 Q4 | - USD | 0.0% |
| 2006 Q2 | - USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| 2004 Q4 | - USD | 0.0% |
| 2004 Q2 | - USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| electroCore, Inc. | 537 Thousand USD | 58.845% |
| NeuroPace, Inc. | 56.95 Million USD | 99.612% |
| Sight Sciences, Inc. | 31.7 Million USD | 99.303% |
| TriSalus Life Sciences, Inc. | 1.24 Million USD | 82.235% |
| SI-BONE, Inc. | 36.06 Million USD | 99.387% |
| Anika Therapeutics, Inc. | 26.9 Million USD | 99.179% |
| Accelerate Diagnostics, Inc. | 36.1 Million USD | 99.388% |
| Cerus Corporation | 59.79 Million USD | 99.63% |
| Axonics, Inc. | 25.84 Million USD | 99.145% |
| 908 Devices Inc. | 3.92 Million USD | 94.375% |
| Treace Medical Concepts, Inc. | 53 Million USD | 99.583% |
| TELA Bio, Inc. | 40.51 Million USD | 99.455% |
| Venus Concept Inc. | 70.79 Million USD | 99.688% |
| Tivic Health Systems, Inc. | 176 Thousand USD | -25.568% |
| RxSight, Inc. | 1.21 Million USD | 81.751% |
| LENSAR, Inc. | 1.75 Million USD | 87.371% |
| Rapid Micro Biosystems, Inc. | 6.21 Million USD | 96.444% |
| LivaNova PLC | 568.54 Million USD | 99.961% |
| Inspira Technologies Oxy B.H.N. Ltd. | 588 Thousand USD | 62.415% |
| Lucid Diagnostics Inc. | 199 Thousand USD | -11.055% |
| Alphatec Holdings, Inc. | 511.03 Million USD | 99.957% |
| Apyx Medical Corporation | 33.18 Million USD | 99.334% |
| Cutera, Inc. | 418.69 Million USD | 99.947% |
| STRATA Skin Sciences, Inc. | 15.04 Million USD | 98.531% |
| BioSig Technologies, Inc. | 103 Thousand USD | -114.563% |
| Integra LifeSciences Holdings Corporation | 1.48 Billion USD | 99.985% |
| Bioventus Inc. | 366.99 Million USD | 99.94% |
| Envoy Medical, Inc. | 404 Thousand USD | 45.297% |
| Helius Medical Technologies, Inc. | 12 Thousand USD | -1741.667% |
| Outset Medical, Inc. | 134.59 Million USD | 99.836% |
| Nexalin Technology, Inc. | - USD | -Infinity% |
| IRIDEX Corporation | 1.75 Million USD | 87.379% |
| PROCEPT BioRobotics Corporation | 51.33 Million USD | 99.57% |
| IRadimed Corporation | 1.61 Million USD | 86.316% |
| PAVmed Inc | 2.96 Million USD | 92.534% |
| INVO Bioscience, Inc. | 6.77 Million USD | 96.739% |
| Movano Inc. | 15.00 USD | -1473233.333% |
| Cytek Biosciences, Inc. | 18.12 Million USD | 98.781% |
| NeuroOne Medical Technologies Corporation | 55.28 Thousand USD | -299.754% |
| Spectral AI, Inc. | - USD | -Infinity% |
| Viemed Healthcare, Inc. | 5.97 Million USD | 96.299% |
| Varex Imaging Corporation | 464.2 Million USD | 99.952% |
| Quipt Home Medical Corp. | 60.82 Million USD | 99.637% |
| IceCure Medical Ltd | 376 Thousand USD | 41.223% |
| Pulmonx Corporation | 35.08 Million USD | 99.37% |
| Modular Medical, Inc. | 817 Thousand USD | 72.95% |
| ReShape Lifesciences Inc. | 151 Thousand USD | -46.358% |
| Insulet Corporation | 1.36 Billion USD | 99.984% |
| Semler Scientific, Inc. | 70 Thousand USD | -215.714% |
| ClearPoint Neuro, Inc. | 9.94 Million USD | 97.779% |
| Orthofix Medical Inc. | 93.1 Million USD | 99.763% |
| InMode Ltd. | 6.61 Million USD | 96.658% |
| Bruker Corporation | 1.14 Billion USD | 99.981% |
| Surmodics, Inc. | 29.4 Million USD | 99.248% |
| Cytosorbents Corporation | 2.54 Million USD | 91.309% |
| iCAD, Inc. | 273 Thousand USD | 19.048% |
| DexCom, Inc. | 2.57 Billion USD | 99.991% |
| Align Technology, Inc. | 96.96 Million USD | 99.772% |
| ZimVie Inc. | 508.79 Million USD | 99.957% |
| Nexalin Technology, Inc. | - USD | -Infinity% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| BrainsWay Ltd. | 239 Thousand USD | 7.531% |
| Tandem Diabetes Care, Inc. | 398.6 Million USD | 99.945% |
| Profound Medical Corp. | 4.97 Million USD | 95.557% |
| enVVeno Medical Corporation | 1.06 Million USD | 79.229% |
| Nano-X Imaging Ltd. | 4.04 Million USD | 94.536% |
| Aethlon Medical, Inc. | 649.75 Thousand USD | 65.987% |
| Inogen, Inc. | 18.27 Million USD | 98.79% |
| MaxCyte, Inc. | 17.96 Million USD | 98.77% |
| iRhythm Technologies, Inc. | 34.95 Million USD | 99.368% |
| OrthoPediatrics Corp. | 13.45 Million USD | 98.358% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| InspireMD, Inc. | 1.03 Million USD | 78.709% |
| PAVmed Inc. | 2.96 Million USD | 92.534% |
| Monogram Orthopaedics, Inc. | 363.72 Thousand USD | 39.24% |
| BIOLASE, Inc. | 13.98 Million USD | 98.42% |
| Beyond Air, Inc. | 14.72 Million USD | 98.499% |
| FONAR Corporation | 37.92 Million USD | 99.417% |
| AxoGen, Inc. | 46.6 Million USD | 99.526% |
| Vivani Medical, Inc. | 19.31 Million USD | 98.856% |
| Tactile Systems Technology, Inc. | 44.61 Million USD | 99.505% |
| Inari Medical, Inc. | 30.35 Million USD | 99.272% |
| UFP Technologies, Inc. | 28 Million USD | 99.211% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 434.04 Thousand USD | 49.084% |
| Co-Diagnostics, Inc. | 2.15 Million USD | 89.731% |
| Tenon Medical, Inc. | 428 Thousand USD | 48.364% |
| Autonomix Medical, Inc. Common Stock | 1 Million USD | 77.944% |
| CVRx, Inc. | 30.38 Million USD | 99.273% |
| AdaptHealth Corp. | 2.09 Billion USD | 99.989% |
| Sintx Technologies, Inc. | 3.68 Million USD | 94.006% |
| Vivos Therapeutics, Inc. | 1.52 Million USD | 85.47% |
| NanoVibronix, Inc. | - USD | -Infinity% |
| Quanterix Corporation | 37.22 Million USD | 99.406% |
| Inspira Technologies Oxy B.H.N. Ltd. | 588 Thousand USD | 62.415% |
| Sensus Healthcare, Inc. | 596 Thousand USD | 62.919% |
| Pacific Biosciences of California, Inc. | 892.24 Million USD | 99.975% |
| TransMedics Group, Inc. | 506.2 Million USD | 99.956% |
| ReWalk Robotics Ltd. | 607 Thousand USD | 63.591% |
| NeuroMetrix, Inc. | 92.48 Thousand USD | -138.958% |
| Hyperfine, Inc. | 64 Thousand USD | -245.313% |
| Establishment Labs Holdings Inc. | 188.73 Million USD | 99.883% |
| Biomerica, Inc. | 459 Thousand USD | 51.852% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 449.48 Thousand USD | 50.832% |
| Bluejay Diagnostics, Inc. | 189.98 Thousand USD | -16.324% |
| Silk Road Medical, Inc | 75.62 Million USD | 99.708% |